Activation of the TLR3/TRIF pathway could down-regulate the levels of TLR4/MyD88, reducing microglial activation and the expression of inflammatory factors to reverse the adverse effects of TLR4 on post-stroke injury. This evidence concerns the gene TLR4 and stroke disorder.